chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 17 hours after the vaccine  I developed chills then shortly after the onset of severe headache.  18-19 hours after the vaccine fever rose and topped off at 101.4 . Headache was intense and pounding  for about 7 hours following the onset of symptoms.  5 hours after the fever topped off at 101.4 it was down to 99.4.  3 hours beyond that it returned to normal. At the onset of symptoms I took one 200mg Ibuprofen tablet and another 6 hours later.  3 hours after each ibuprofen I took 2 500mg Acetaminophen tablets. by approximately 30-31 hours following the vaccine all adverse affects appeared to have gone away.
Information has been received from a Licensed Vocational Nurse (L.V.N) referring to a patient of unknown age and unknown gender. History medication and drug allergies were not reported. On 16-MAY-2015 the patient was vaccinated with a dose of incorrect stored ECOMBIVAX HB (dose, strength and route were not reported) (lot# K017721, expire date 27-AUG-2016). Concomitant drug was no reported. At the time of reporting, no adverse effects was reported and it was unspecified if the patient sought any medical attention. This is one of several reports received from the same reporter. Additional information has been requested.
Patient states she had swelling of the neck.  Tried to determine over the phone if it was the lymph nodes and pt was not sure what the lymph nodes were or where the swelling was exactly, just stated that her neck was swelling up.
feeling light headed; vertigo sensation; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 54 year-old patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) for 1 day at the age of 54 years as dose 1,single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "feeling light headed"; VERTIGO (non-serious), outcome "unknown", described as "vertigo sensation".  Additional information: The patient got the first injection on Tuesday the 23rd and about a week later, when woke up and had a vertigo sensation and feeling light headed, patient had this the last 3 mornings. It gets better as the day goes on but the first three hours are bad. The patient wants to know is this a normal side effect of the vaccine?. The patient stated whether there is a need to take the second shot of vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a nurse referring to unspecified patients of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies and concomitant medication were not reported. On unknown dates, the patients were vaccinated with 20 doses of improperly stored GARDASIL 9 (lot # was reported as K010215 (invalid) with expiration date 05-MAY-2017; dose and route were not reported). No adverse effects were reported. Additional information has been requested.
Pt arrived to the hospital with fatigue, myalgias and joint pain, and shortness of breath. The patient has COPD and is oxygen dependent. She tested positive for COVID-19. She was admitted for acute hypoxic respiratory failure and COVID-19.
Patient stated he was injected twice by the vaccinator, LPN, during his vaccine administration. Patient was concerned that he may have been poked with a dirty needle and then given the actual vaccine. He stated that administered the first syringe when he commented that it burned. He stated told him there wasn't anything in that one and then administered the actual vaccine. The patient showed his arm, where it did in his opinion, appear there were two needle marks in his deltoid region. He discussed the issue with LPN. Her story was inconsistent as she repeated what happened. She stated she did not inject the patient twice.  She denies using a dirty syringe on the patient and stated she immediately throws her dirty needles in the sharp's container. HE interviewed LPN with someone else present. Initially stated she did not inject the patient twice. She later stated that she did poke the patient twice: the first time is when the patient complained it burned, she stated she pulled the needle out and then proceeded to use the same needle and injected the patient with the same needle. He informed LPN that he advised against that practice and that her story had changed from the previous versions. He informed her that he was sending her home immediately.
Pt developed pruritic rash, two days later, low grade fever 99.7F & experienced n,v; On, 26FEB90, eyelids were swollen;
COVID 19; COVID 19; Vaccine brand other: Moderna; Vaccine brand: Pfizer/BioNTech; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 59-year-old male patient received BNT162b2 (BNT162B2), on 22Mar2021 at 12:30 as dose 1, single (Lot number: Er2613), in right arm, on 12Apr2021 at 14:15 as dose 2, single (Lot number: Ew0162), in left arm, on 09Apr2022 at 12:15 as dose 3 (booster), single (Lot number: Fic9893), in right arm and on 12Apr2022 at 14:30 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 59 years, in right arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 14Nov2021 at 15:45 as dose 4 (booster), single (Lot number: 069f21a), in right arm and on 07Oct2022 at 13:15 as dose 6 (booster), single (Lot number: 053d22a), in right arm for covid-19 immunisation. The patient had no relevant medical history. No known allergies. The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 12Apr2022 at 14:30, outcome "unknown", described as "Vaccine brand other: Moderna; Vaccine brand: Pfizer/BioNTech"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) positive, notes: Treatment of COVID-19; (Feb2023) positive, notes: positive covid test. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Antiviral details included COVID 19 Treatment with Brand Paxlovid (Treatment start date: 07Feb2023, Treatment stop date: 12Feb2023) for Indication Treatment of COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I had a miscarriage at my 18 week check-up. They estimated the baby died around 16 weeks and 5 days. I had gotten my 1st covid vaccine shot at 15 weeks pregnant. My baby had been healthy with no genetic disorders detected at the time of the miscarriage. I don?t know if this could be related to the vaccine, but wanted to report.
Initial and follow up information has been received from a nurse practitioner concerning a 12 month old white male with drug hypersensitivity to amoxicillin who on 5/29/04 was vaccinated in the left arm with the first dose of MMR (lot # 644577/1037M). The nurse practitioner reported that the patient was seen prior to 6/1/04 for, what she thought at the time, a viral rash post vaccination. The patient's condition worsened and on 6/8/04, the patient presented to the doctor's office with head to toe measles, rash, fever, and conjunctivitis. The patient was treated with vitamin A. Titers were drawn but the results were not reported. At the time of this report, the patient had recovered from the events Additional information has been requested.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No pertinent medical history, drug reactions or allergies and concomitants were reported. On 02-JUL-2015, the patient was vaccinated with an expired dose of ZOSTAVAX (lot # J011338, expiration date 19-DEC-2014) (dose, route of administration and indication were not reported). No adverse effect was reported. Additional information has been requested.
I didn't have a reaction at first until a couple days later, about 5 days. I had my right eye swollen around the top eyelid and it was itchy. It didn't affect my vision; my primary doctor prescribed some antibiotics and steroid and allergy medication. My doctor said I possibly had a bacterial infection before and the vaccine aggravated it.
Pt received 5 vaccinations (Hep A, Hep B, Varicella, Meningococcal, and TdaP). Immediately after injection, pt had syncopal episode. Was responsive and oriented to place and time following being placed in supine position, but continued to close eyes immediately after stimulus for several minutes following injections. VS were normal. Exam normal. Pt placed in Trendelenburg position and given IV fluids. Glucose level 73. ECG normal. Orthostatic BPs normal. EMS responded, but parent refused transport. Pt eventually returned to normal.
1st Vaccine: Soreness in arm, fatigue 2nd Vaccine:    Day 1: Soreness in arm, fatigue, chills, heaviness in head    Day 3: Nausea, vomiting, chills, fatigue, body aches, fever    Day 7: Shingles confirmed via swab
Fever CHILLS, NAUSEA, BODY ACHES ARM SORENESS, FATIGUE, ITCHY ARM
BECAME ITCHY & FELT SWELLING TO LIPS; HAD RASH ALL OVER BODY; EPI-PEN ADMINISTERED & 25 MG BENADRYL (IM & PO DOSES).
This spontaneous report as received from a pharmacist refers to a female patient of unknown age with penicillin (manufacture unknown) allergy and codeine (manufacture unknown) allergy. On an unknown date, patient developed allergic reaction to codeine (manufacture unknown) and penicillin (unspecified) (manufacture unknown). On an unknown date, patient was vaccinated with first dose of PNEUMOVAX 23 (strength, dose unit, route, lot# and expiry date unknown). On 07-MAR-2014, the patient was vaccinated with booster dose of PNEUMOVAX 23 0.5 ml with lot number (J010395) and expiry date 16-FEB-2015 intramuscularly. On 07-MAR-2014, 5 hours later, patient experienced severe arm pain and called pharmacist for medical attention and she had no problems with the first dose of PNEUMOVAX 23. No laboratory tests were performed. the outcome of severe arm pain was reported as not recovered/not resolved. No further information was provided. This case # 1403USA004795 is linked to case # 1403USA005016 and 1403USA005017 via same patient link. Additional information has been requested.
Family reports child with excess thirst 11.02, then awoke 11/03/04 with painful swelling of left side of face. Seen in office 11/03/04 with Dx of parotitis. Treated symptomatically.
Vaccine given to a 16 year old; Headache; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine given to a 16 year old), HEADACHE (Headache) and MYALGIA (Arm pain) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A. Expiration date unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine given to a 16 year old), HEADACHE (Headache) and MYALGIA (Arm pain). On 03-May-2021, HEADACHE (Headache) and MYALGIA (Arm pain) had resolved. At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine given to a 16 year old) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported. The treatment information was unknown. Action taken with mRNA-1273 in response to the events were not applicable.  Vaccination was given to the patient whose age was below18 years old.
Dry mouth; a metallic taste in  mouth; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry mouth) and DYSGEUSIA (a metallic taste in  mouth) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced DRY MOUTH (Dry mouth) and DYSGEUSIA (a metallic taste in  mouth). At the time of the report, DRY MOUTH (Dry mouth) and DYSGEUSIA (a metallic taste in  mouth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
pt recvd vax & had 1 cm wheal; 4cm flare w/in 5 min, resolved p/ approx 30 min;
Skin eruption or rash all over body; This is a spontaneous report from a Non-contactable consumer(patient).   A 19-year-old non pregnant female patient bnt162b2 (Pfizer-Biontech Covid-19 Vaccine, Solution for injection, batch/lot number not provided), via an unspecified route of administration on an unspecified date in 2021 (at the age of 19 year), as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient experienced skin eruption or rash all over body. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received Prednisone as a treatment medication. The patient was visited to Doctor or other healthcare professional office/clinic visit for the event. The event was resolved on an unspecified date in 2021.  The reporter did not consider the event to be serious.  No follow-up attempts were possible; information about lot/batch number could not be obtained.
Information has been received from a RN concerning a 39 year old female with no known allergies and no relevant medical history who on 3/27/03 was vaccinated at 13:00 IM in the left deltoid with a first dose of hep B vaccine (643395/0429M).There was no illness at the time of vaccination. On 3/27/03, within a few hours after vaccination, the pt developed a severe headache described as pain on the right side of her head that started at 15:00 and "continued through the night into the next morning and afternoon," stiff neck and sweating of the entire body. There was no relevant diagnostic lab data. On 3/8/03, the pt was seen in the ER and was diagnosed with possible sinus infection vs. migraine. The pt was treated with Keflex and a cough medicine. By 3/29/03, the conditions had resolved. It was noted that the pt forgot to tell the ER that she had received the vaccine. It was reported that the pt "was advised by her private physician not receive any more doses of hep B." Prescription drug treatment was required. No further info is expected.
Left shoulder local rash(5x5cm), no prutitus, mild local muscle pain+, no general sx, started on Satureday 9/23/17. This patient took Tylenol po once on Saturday, and pain resolved. Rash became smaller and got better.
Myalgia, Diarrhea, Red, sore, itchy, and hard at injection site Narrative:
Heart racing, felt VERY jittery and uncomfortable. Heart rate went to 180 at one point.
On May 22, 2018 patient came into the pharmacy and asked if he should get a second SHINGRIX shot. He said he had a rash that has not gone away since he got the shot on 4/2/2018. He showed me his left shoulder. It had six "pock marks" of varying sizes. When asked he said they were itchy but not excessive.
Blood clots left arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 46-year-old male patient received BNT162b2 (BNT162B2), on 04Nov2021 as dose 2, single (Lot number: FD0810) at the age of 46 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: FD0810 BUD, Location of injection: Arm Left), administration date: 14Oct2021, when the patient was 46-year-old, for Covid-19 immunization. The following information was reported: THROMBOSIS (medically significant) with onset 02Apr2022, outcome "recovering", described as "Blood clots left arm". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Nasal Swab. Therapeutic measures were taken as a result of thrombosis.  Clinical information: The patient was treated with Xarelto. Patient did not received any other vaccine in four weeks and other medications in two weeks. Patient did not have any COVID prior to vaccination.  No follow-up attempts are possible. No further information is expected.
Per MD office - raised red area about 3x5 inch on upper back of left arm. Treatment per MD - ice compress and Azithromycin.
Per patient: patient developed sore/swollen glands on neck on 1/23/2021 (morning after receiving vaccine). Lymph nodes along clavicle on right side are swollen/sore as well. Patient went to provider's office on Monday (1/25/2021) for symptoms. Patient states that lymph nodes on neck are better today, but lymph nodes along clavicle on right side continue to worsen. Patient is in contact with her provider.
After the 1st vaccine, a week later I started my cycle. I thought it was normal. I bled for approximately 5 days, which is normal for me. Less than a week later, I was having weird, long, stringy clots. It reminded me of an abruption since the blood was burgundy in color. It was 3 days, but it still required a tampon. Then a week and 3 days later, I started bleeding again, but that time was for 8 days. At that point, that's when I called my OB and reported it on my V-safe. I didn't have the usual premenstrual symptoms. They did a pregnancy test, an ultrasound, lab work and a speculum pap exam, which including swabbing. The tests revealed nothing, so they told me that I'm getting old and maybe I'm just changing. After that, it didn't happen again and I've had my normal cycle since then.  With exception of a sore arm, I didn't have any other side effects from the vaccine.
An 8 year old was administered a booster dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (An 8 year old was administered a booster dose of the Moderna COVID-19 vaccine) in an 8-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer vaccine (Date of First Dose: 12NOV2021 LOT# of First Dose: FK5127 (Pfizer) Expiration: Unknown Arm: Left Non Dominant) on 12-Nov-2021. Past adverse reactions to the above products included No adverse event with Pfizer vaccine.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (An 8 year old was administered a booster dose of the Moderna COVID-19 vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (An 8 year old was administered a booster dose of the Moderna COVID-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not provided by the reporter. Treatment information was not provided. Patient administered a second dose of unknown vaccine on 03DEC2021 on Left Non Dominant arm with unknown lot number and expiration.
approx 4hr p/vax lt upper arm swollen, exquisitely tender to touch, erythema tx elevation, warm packs, APAP resolved p/48 hr;
Metallic taste in mouth and numbness of tongue - kind of like licking a battery.  Started about 30 minutes after vaccination. Has been coming in and out for about a week now. Currently very strong. Not worried about it, but thought it was worth reporting.
Pt recvd vax approx 1030AM & approx 1230 shaky, t102 as precautionary measure; MD adm to hosp for 1 day observation; exam revealed ear infect; pt improved p/receiving antibiotics;
ON 1/1/21 THE DAY AFTER I RECEIVED THE VACCINE I WAS TAKING A NAP AND MY WATCH KEPT SENDING ME ALERTS. HOWEVER I DID NOT CHECK MY WATCH UNTIL 5:30 WHEN I WOKE UP AND I FELT LIKE I WAS HAVING HEART PALPITATIONS. I WENT TO THE EMERGENCY ROOM WHERE I WAS TREATED. I WAS TOLD THAT I WAS FEBRILE WITH A TEMPERATURE OF 102. I WAS GIVEN IV FLUIDS, CHEST X-RAY, EKG AND LAB WORK. I WAS RELEASED ON 1/2/21 AT APPROXIMATELY 0030 (MIDNIGHT).
has a rash on his upper back; feels a little bit itchy on his upper back; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 64-years-old male patient reported for himself that he received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6205, NDC number, Expiration date: unknown), via an unspecified route of administration on 15Mar2021 (age at vaccination was 64-years-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient took covid-19 vaccine for prevention for covid-19 virus and doesn't want to die. Medical history included high blood pressure, high cholesterol and allergic to aspirin; all from an unknown date and unknown if ongoing. Concomitant medications included atenolol 25 mg and losartan 100 mg, both taken for high blood pressure and rosuvastatin 5 mg taken for high cholesterol; all start and stop date were not reported. Report stated as, the patient had the first dose of the PFIZER-BIONTECH COVID-19 VACCINE 15Mar2021 - After 24 hours he developed rashes on his upper back - He described the rashes itchy - reported the side effect - Asking how long will the rashes last and if this is a reported case. Additional context reported as, the patient got first shot of COVID-19 vaccine yesterday, 15Mar2021. This afternoon, on 16Mar2021, the patient feels a little bit itchy on his upper back. Told his wife to check. Wife stated patient has a rash on his upper back. Admission to the hospital due to event was reported as unknown. The patient was concerned about second dose and wanted to know if it is ok for him to take it. The patient saw his doctor every six months and had no lab work since covid-19 vaccine. Treatment received was reported as unknown. No investigation assessment was reported. Outcome of the events was unknown.   Follow-up attempts completed. No further information expected.
Vaccinated child broke out with > 200 lesions, vax was given 5 years ago. Office was concerned about child developing varcella and wanted it reported.
swelling and soreness at admin site; fever aches for 12 hours that evening; large swelling in arm pit for 5 additional days
Pt recvd Engerix-B on the following dates 28MAY91, 28JUN91, 28NOV91 & blood drawn in APR or MAY92 showed a titer value of 7.9;
Patient states that she received her first COVID vaccine (Moderna) on 01/26/2021. 2 hours after receiving the vaccine she had severe abdominal cramping. Patient states that this pain lasted 48 hours. Pt denies having any other symptoms.
It was reported that the patient experienced redness and irritation around the injection site the day after administration.